JP Morgan Chase’s Myovant Sciences Ltd. MYOV Stock Holding History

JP Morgan Chase’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,000	Closed	-$253K	–	7108
2022 Q1	$253K	Hold	19,000	–	–	﹤0.01%	5070
2021 Q4	$296K	Buy	+19,000	New	+$363K	﹤0.01%	5140

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's MYOV Position: Q1 2023 in Review

JP Morgan Chase sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 53,492 shares — an estimated $1.44M sold.

JP Morgan Chase first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $3.37M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

JP Morgan Chase reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
JP Morgan Chase sold 53,492 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.44M.
JP Morgan Chase first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
JP Morgan Chase's Myovant Sciences Ltd. position peaked at $3.37M in Q3 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.